Institutional & Family Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7
Closed 725
2022
Q3
$0 Sell
7
-10
-59% -$457 ﹤0.01% 708
2022
Q2
$1K Sell
17
-5
-23% -$237 ﹤0.01% 627
2022
Q1
$1K Sell
22
-1
-4% -$65 ﹤0.01% 673
2021
Q4
$2K Hold
23
﹤0.01% 646
2021
Q3
$2K Sell
23
-16
-41% -$1.23K ﹤0.01% 754
2021
Q2
$3K Buy
39
+13
+50% +$945 ﹤0.01% 765
2021
Q1
$2K Sell
26
-16
-38% -$985 ﹤0.01% 775
2020
Q4
$2K Buy
42
+20
+91% +$865 ﹤0.01% 746
2020
Q3
$1K Buy
+22
New +$933 ﹤0.01% 764

Other funds holding ATRC

Institutional & Family Asset Management's ATRC Position: Q4 2022 in Review

Institutional & Family Asset Management sold out of AtriCure (ATRC) in Q4 2022, closing a stake of 7 shares.

Institutional & Family Asset Management first reported a position in ATRC in Q3 2020 and held it in 9 quarters. The position peaked at $3K in Q2 2021. 211 funds tracked by Wall St. Rank hold ATRC as of Q4 2022.

  • Institutional & Family Asset Management reported no remaining AtriCure position as of Q4 2022 after selling out during the quarter.
  • Institutional & Family Asset Management sold 7 AtriCure shares in Q4 2022.
  • Institutional & Family Asset Management first reported a position in AtriCure in Q3 2020 and held it in 9 quarters.
  • Institutional & Family Asset Management's AtriCure position peaked at $3K in Q2 2021.
  • 211 funds tracked by Wall St. Rank held AtriCure as of Q4 2022.

Based on Institutional & Family Asset Management's 13F filing for Q4 2022, filed 8 Feb 2023.